GLRE:NASDAQGreenlight Reinsurance, Ltd. Analysis

Greenlight Capital Re (GLRE) is trading at $17.93, comfortably above the calculated support of $16.90 and below resistance at $19.26, with the 20‑day SMA ($18.07) sitting just above the current price, indicating a near‑term pull‑back within an overall bullish framework (20‑day SMA > 50‑day SMA > 200‑day SMA).
The stock appears deeply undervalued: its trailing P/E of 7.6 is less than half the industry average of 16.7, the price‑to‑book ratio of 0.81 is below 1.0, and the DCF‑derived fair value of $109.9 suggests a massive upside potential. Recent Q1 2026 results showed a strong combined ratio of 96%, net income of $35.8 million and earnings of $1.05 per share, accompanied by a $5 million share repurchase, reinforcing the company’s cash generation despite a –6.9% revenue decline. With a low beta of 0.45, stable volume, and a solid balance sheet (cash $75 M vs debt $7.7 M), the risk‑adjusted profile is attractive, though the 30‑day volatility of 23.5% and a max drawdown of ~20% warrant caution.